Works matching DE "TIPRANAVIR (Drug)"
Results: 22
Emerging HIV-1 resistance to tipranavir and darunavir in patients with virological failure to first-generation protease inhibitors in Taiwan.
- Published in:
- International Journal of STD & AIDS, 2011, v. 22, n. 11, p. 617, doi. 10.1258/ijsa.2009.009007
- By:
- Publication type:
- Article
Pharmacokinetic profile in late pregnancy and cord blood concentration of tipranavir and enfuvirtide.
- Published in:
- International Journal of STD & AIDS, 2011, v. 22, n. 5, p. 294, doi. 10.1258/ijsa.2009.009166
- By:
- Publication type:
- Article
Effects of enzyme inducers efavirenz and tipranavir/ritonavir on the pharmacokinetics of the HIV integrase inhibitor dolutegravir.
- Published in:
- European Journal of Clinical Pharmacology, 2014, v. 70, n. 10, p. 1173, doi. 10.1007/s00228-014-1732-8
- By:
- Publication type:
- Article
Switching from tipranavir (TPV) 500/ritonavir (RTV) 200 mg to TPV 500/RTV 100 mg in treatment-experienced patients (pts) with HIV RNA <50 copies/mL.
- Published in:
- Journal of the International AIDS Society, 2010, v. 13, p. P49, doi. 10.1186/1758-2652-13-S4-P49
- By:
- Publication type:
- Article
Switching from tipranavir (TPV) 500/ritonavir (RTV) 200 mg to TPV 500/RTV 100 mg in treatment-experienced patients (pts) with HIV RNA <50 copies/mL.
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Tipranavir//Ritonavir Induction of Buprenorphine Glucuronide Metabolism in HIV-Negative Subjects Chronically Receiving Buprenorphine//Naloxone.
- Published in:
- American Journal of Drug & Alcohol Abuse, 2011, v. 37, n. 4, p. 224, doi. 10.3109/00952990.2011.568081
- By:
- Publication type:
- Article
Effectiveness of tipranavir versus darunavir as a salvage therapy in HIV-1 treatment-experienced patients.
- Published in:
- Journal of Infection in Developing Countries, 2016, v. 10, n. 9, p. 982, doi. 10.3855/jidc.6629
- By:
- Publication type:
- Article
2018 update to the HIV-TRePS system: the development of new computational models to predict HIV treatment outcomes, with or without a genotype, with enhanced usability for low-income settings.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Highly multidrug-resistant HIV: clonal analysis and therapeutic strategies.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 12, p. 2882, doi. 10.1093/jac/dkt272
- By:
- Publication type:
- Article
Efficacy and safety of raltegravir in treatment-experienced HIV-1-infected patients switching from enfuvirtide-based regimens: 48 week results of the randomized EASIER ANRS 138 trial.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 9, p. 2099
- By:
- Publication type:
- Article
Lack of a pharmacokinetic interaction between steady-state tipranavir/ritonavir and single-dose valacyclovir in healthy volunteers.
- Published in:
- European Journal of Clinical Pharmacology, 2011, v. 67, n. 3, p. 277, doi. 10.1007/s00228-010-0907-1
- By:
- Publication type:
- Article
Use of Third Line Antiretroviral Therapy in Latin America.
- Published in:
- PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0106887
- By:
- Publication type:
- Article
Virologic Response to Tipranavir-Ritonavir or Darunavir-Ritonavir Based Regimens in Antiretroviral Therapy Experienced HIV-1 Patients: A Meta-Analysis and Meta-Regression of Randomized Controlled Clinical Trials.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0060814
- By:
- Publication type:
- Article
HIV Protease Inhibitors Act as Competitive Inhibitors of the Cytoplasmic Glucose Binding Site of GLUTs with Differing Affinities for GLUT1 and GLUT4.
- Published in:
- PLoS ONE, 2011, v. 6, n. 9, p. 1, doi. 10.1371/journal.pone.0025237
- By:
- Publication type:
- Article
Added Value of Deep Sequencing Relative to Population Sequencing in Heavily Pre-Treated HIV-1-Infected Subjects.
- Published in:
- PLoS ONE, 2011, v. 6, n. 5, p. 1, doi. 10.1371/journal.pone.0019461
- By:
- Publication type:
- Article
Antiretroviral therapy- newer drugs on the anvil.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients: A Randomized, Multinational, Multicenter Trial.
- Published in:
- PLoS ONE, 2016, v. 11, n. 1, p. 1, doi. 10.1371/journal.pone.0144917
- By:
- Publication type:
- Article
Metal-Free Aminosulfonylation of Aryldiazonium Tetrafluoroborates with DABCO⋅(SO<sub>2</sub>)<sub>2</sub> and Hydrazines.
- Published in:
- Angewandte Chemie, 2014, v. 126, n. 9, p. 2483, doi. 10.1002/ange.201309851
- By:
- Publication type:
- Article
Clinical Pharmacology Profile of Raltegravir, an HIV-1 Integrase Strand Transfer Inhibitor.
- Published in:
- Journal of Clinical Pharmacology, 2011, v. 51, n. 10, p. 1376, doi. 10.1177/0091270010387428
- By:
- Publication type:
- Article
Effect of Tipranavir/Ritonavir Combination on the Pharmacokinetics of Tadalafil in Healthy Volunteers.
- Published in:
- Journal of Clinical Pharmacology, 2011, v. 51, n. 7, p. 1071, doi. 10.1177/0091270010379808
- By:
- Publication type:
- Article
Boosted Tipranavir versus Darunavir in Treatment-Experienced Patients Observational Data from the Randomized POTENT Trial.
- Published in:
- Drugs in R&D, 2011, v. 11, n. 4, p. 295, doi. 10.2165/11596340-000000000-00000
- By:
- Publication type:
- Article
Tipranavir in the Protease Inhibitors Arena.
- Published in:
- 2011
- By:
- Publication type:
- Opinion